Avalo Therapeutics Inc (AVTX)
9.50
-0.14
(-1.45%)
USD |
NASDAQ |
May 17, 16:00
9.50
0.00 (0.00%)
After-Hours: 19:07
Avalo Therapeutics Total Assets (Quarterly): 20.99M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.99M |
| September 30, 2023 | 29.27M |
| June 30, 2023 | 24.24M |
| March 31, 2023 | 36.24M |
| December 31, 2022 | 33.37M |
| September 30, 2022 | 36.55M |
| June 30, 2022 | 32.22M |
| March 31, 2022 | 61.90M |
| December 31, 2021 | 80.21M |
| September 30, 2021 | 95.36M |
| June 30, 2021 | 64.08M |
| March 31, 2021 | 63.34M |
| December 31, 2020 | 43.76M |
| September 30, 2020 | 59.19M |
| June 30, 2020 | 69.20M |
| March 31, 2020 | 44.12M |
| December 31, 2019 | 36.11M |
| September 30, 2019 | 57.19M |
| June 30, 2019 | 59.62M |
| Date | Value |
|---|---|
| March 31, 2019 | 74.87M |
| December 31, 2018 | 70.25M |
| September 30, 2018 | 67.61M |
| June 30, 2018 | 62.15M |
| March 31, 2018 | 65.36M |
| December 31, 2017 | 42.81M |
| September 30, 2017 | 28.20M |
| June 30, 2017 | 6.048M |
| March 31, 2017 | 3.561M |
| December 31, 2016 | 5.769M |
| September 30, 2016 | 9.583M |
| June 30, 2016 | 13.17M |
| March 31, 2016 | 16.93M |
| December 31, 2015 | 21.66M |
| September 30, 2015 | 5.451M |
| June 30, 2015 | 7.582M |
| March 31, 2015 | 9.170M |
| December 31, 2014 | 12.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
20.99M
Minimum
Dec 2023
95.36M
Maximum
Sep 2021
49.84M
Average
44.12M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Imunon Inc | 21.92M |
| iBio Inc | 34.02M |
| Kodiak Sciences Inc | 479.37M |
| Petros Pharmaceuticals Inc | 33.80M |
| Ocugen Inc | 51.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.69M |
| Shareholders Equity (Quarterly) | 7.304M |
| Current Ratio | 1.818 |
| Net Debt Paydown Yield | 52.27% |